Akso Health Group (AHG) Q2 2024 Earnings Report

AHG reported QQ2 2024 results showing a sharp year-over-year and quarter-over-quarter revenue decline, accompanied by negative profitability metrics. Revenue of 446,792 (USD) declined 92.5% YoY and 41.2% QoQ, yielding a gross profit of 19,415 and a gross margin of 4.35%. Operating income Turned negative at -1,157,924 and net income was -1,532,088 with an EPS of -0.20. The company carries a clearly negative earnings trajectory despite a solid liquidity position: cash and cash equivalents of 9,211,639 and a net cash position of -8,861,639 (net debt), underpinning financial flexibility. On the balance sheet, AHG exhibits a healthy current ratio of 1.46 and a cash ratio of 0.798, with total assets of 16,880,618 and total liabilities of 11,549,145. Operating cash flow was modest at 121,168, while net cash provided by operating activities helped fund investing and financing activities, and FX effects contributed positively to cash. These dynamics suggest the quarter was characterized by structural revenue normalization challenges and ongoing profitability pressures, even as liquidity supports potential strategic pivots and working-capital optimization.